LRG1 and eye disorder: Pathological levels of LRG1 on the other hand, frequently driven by ectopic overexpression of LRG1 at the sites of pathology as observed in some cancers, inflammatory conditions and eye disease, have strong biological activity which appears, at least in part, mediated by coercion of TGFβ signalling (Fig. 3).